NCT01694095

Brief Summary

Age-related macular degeneration is one of the leading causes of blindness worldwide. The factors that induce the progression of geographic atrophy, the advanced form of dry age-related macular degeneration, remain poorly understood. The aims of this study are to describe the natural history of geographic atrophy and identify potential risk factors associated with a faster spread of atrophy that may be used to develop rational therapies.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
96

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Dec 2009

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 1, 2009

Completed
2.8 years until next milestone

First Submitted

Initial submission to the registry

September 22, 2012

Completed
4 days until next milestone

First Posted

Study publicly available on registry

September 26, 2012

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2013

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2013

Completed
Last Updated

March 24, 2015

Status Verified

March 1, 2015

Enrollment Period

3.7 years

First QC Date

September 22, 2012

Last Update Submit

March 23, 2015

Conditions

Keywords

Geographic atrophy, prognosis, risk factors, natural history

Outcome Measures

Primary Outcomes (1)

  • Median/mean change in area of geographic atrophy as measured in mm2 with fundus autofluorescence on a 30º image centered on field 2

    For measures related to change in the area of atrophy, a multivariable model will be fit and will include as an independent variable (amongst other presumed risk factors) fundus autofluorescence patterns

    From baseline to last follow-up

Secondary Outcomes (1)

  • Median change in area of geographic atrophy as measured in square root of mm2 with fundus autofluorescence on a 30º image centered on field 2

    From baseline to last follow-up

Other Outcomes (3)

  • Median/mean change in best-corrected visual acuity as measured with an Early Treatment Diabetic Retinopathy Study chart

    From baseline to last follow-up

  • Percentage of eyes developing new choroidal neovascularization in the study eye as evaluated with fluorescein angiography and spectral-domain optical coherence tomography

    From baseline to last follow-up

  • Median/mean change in area of geographic atrophy as measured in mm2 with fundus autofluorescence on a 30º image centered on field 2

    From baseline to last follow-up

Study Arms (1)

Patients with geographic atrophy

Eligibility Criteria

Age50 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients with geographic atrophy

You may qualify if:

  • Both sexes
  • years of age or older
  • Uni or bilateral areas of geographic atrophy in the macula (as defined as areas devoid of retinal pigment epithelium measuring at least 0.5 disk areas on a 35º fundus photograph centered on field 2) secondary to age-related macular degeneration
  • Willing to provide Informed consent

You may not qualify if:

  • Other causes of geographic atrophy aside from age-related macular degeneration (ie, drug induced, central serous chorioretinopathy)
  • Prior history of wet age-related macular degeneration
  • Other significant concomitant macular diseases (ie, significant epiretinal membrane, stage II-IV macular hole)
  • Previous treatment with macular laser photocoagulation, photodynamic therapy, antiangiogenic drugs or other treatments for wet age-related macular degeneration
  • Intraocular surgery aside from phacoemulsification
  • Inability to measure the full extent of the area of atrophy on a 35º fundus autofluorescence image centered on field 2
  • Areas of geographic atrophy in direct contact with peripapillary areas of atrophy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Institut de la màcula i de la retina

Barcelona, Barcelona, 08017, Spain

Location

Related Publications (4)

  • Biarnes M, Mones J, Trindade F, Alonso J, Arias L. Intra and interobserver agreement in the classification of fundus autofluorescence patterns in geographic atrophy secondary to age-related macular degeneration. Graefes Arch Clin Exp Ophthalmol. 2012 Apr;250(4):485-90. doi: 10.1007/s00417-011-1846-y. Epub 2011 Oct 28.

  • Mones J, Biarnes M, Trindade F. Hyporeflective wedge-shaped band in geographic atrophy secondary to age-related macular degeneration: an underreported finding. Ophthalmology. 2012 Jul;119(7):1412-9. doi: 10.1016/j.ophtha.2012.01.026. Epub 2012 Mar 21.

  • Mones J, Biarnes M, Trindade F, Arias L, Alonso J. Optical coherence tomography assessment of apparent foveal swelling in patients with foveal sparing secondary to geographic atrophy. Ophthalmology. 2013 Apr;120(4):829-36. doi: 10.1016/j.ophtha.2012.09.054. Epub 2013 Jan 3.

  • Biarnes M, Forero CG, Arias L, Alonso J, Mones J. Reappraisal of geographic atrophy patterns seen on fundus autofluorescence using a latent class analysis approach. Invest Ophthalmol Vis Sci. 2014 Nov 18;55(12):8302-8. doi: 10.1167/iovs.13-13542.

MeSH Terms

Conditions

Geographic Atrophy

Condition Hierarchy (Ancestors)

Macular DegenerationRetinal DegenerationRetinal DiseasesEye Diseases

Study Officials

  • Jordi Monés, MD, PhD

    Institut de la màcula i de la retina

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
MD, PhD

Study Record Dates

First Submitted

September 22, 2012

First Posted

September 26, 2012

Study Start

December 1, 2009

Primary Completion

August 1, 2013

Study Completion

August 1, 2013

Last Updated

March 24, 2015

Record last verified: 2015-03

Locations